1. Home
  2. CDT vs EEIQ Comparison

CDT vs EEIQ Comparison

Compare CDT & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • EEIQ
  • Stock Information
  • Founded
  • CDT 2019
  • EEIQ 2017
  • Country
  • CDT United States
  • EEIQ United States
  • Employees
  • CDT N/A
  • EEIQ N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • EEIQ Other Consumer Services
  • Sector
  • CDT Health Care
  • EEIQ Real Estate
  • Exchange
  • CDT Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • CDT 10.9M
  • EEIQ 10.7M
  • IPO Year
  • CDT N/A
  • EEIQ 2021
  • Fundamental
  • Price
  • CDT $0.11
  • EEIQ $1.00
  • Analyst Decision
  • CDT
  • EEIQ
  • Analyst Count
  • CDT 0
  • EEIQ 0
  • Target Price
  • CDT N/A
  • EEIQ N/A
  • AVG Volume (30 Days)
  • CDT 34.8M
  • EEIQ 58.9K
  • Earning Date
  • CDT 11-14-2024
  • EEIQ 01-06-2025
  • Dividend Yield
  • CDT N/A
  • EEIQ N/A
  • EPS Growth
  • CDT N/A
  • EEIQ N/A
  • EPS
  • CDT N/A
  • EEIQ N/A
  • Revenue
  • CDT N/A
  • EEIQ $6,454,461.00
  • Revenue This Year
  • CDT N/A
  • EEIQ N/A
  • Revenue Next Year
  • CDT N/A
  • EEIQ N/A
  • P/E Ratio
  • CDT N/A
  • EEIQ N/A
  • Revenue Growth
  • CDT N/A
  • EEIQ 13.32
  • 52 Week Low
  • CDT $0.08
  • EEIQ $0.60
  • 52 Week High
  • CDT $7.83
  • EEIQ $2.19
  • Technical
  • Relative Strength Index (RSI)
  • CDT 52.44
  • EEIQ 72.52
  • Support Level
  • CDT $0.08
  • EEIQ $0.78
  • Resistance Level
  • CDT $0.10
  • EEIQ $1.05
  • Average True Range (ATR)
  • CDT 0.02
  • EEIQ 0.07
  • MACD
  • CDT 0.00
  • EEIQ 0.02
  • Stochastic Oscillator
  • CDT 33.24
  • EEIQ 84.08

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University.

Share on Social Networks: